Published in Thorax on March 01, 1985
The role of airway mucus in pulmonary toxicology. Environ Health Perspect (1994) 1.02
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma. J Clin Invest (1996) 1.00
Impaired tracheobronchial clearance in bronchiectasis. Thorax (1987) 0.99
Effect of inhaled dust mite allergen on regional particle deposition and mucociliary clearance in allergic asthmatics. Clin Exp Allergy (2011) 0.98
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. Clin Chest Med (2015) 0.76
Acute effect of inhaled bradykinin on tracheobronchial clearance in normal humans. Thorax (1992) 0.75
Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel. Sci Rep (2016) 0.75
Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis. Thorax (1997) 0.75
The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis (1976) 6.52
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis (1978) 1.24
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment. Arch Environ Health (1973) 1.15
Tracheobronchial clearance in patients with influenza. Am Rev Respir Dis (1973) 1.14
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
Sputum and ciliary inhibition in asthma. Thorax (1982) 1.00
Mucus clearance from the airways in chronic bronchitis--Smokers and ex-smokers. Bull Eur Physiopathol Respir (1982) 0.93
Drug effects on mucociliary function. Eur J Respir Dis Suppl (1983) 0.93
A model for assessing bronchial mucus transport. J Nucl Med (1984) 0.91
The importance of aerosol penetration for lung mucociliary clearance studies. Chest (1981) 0.89
Lung mucociliary function in man: interdependence of bronchial and tracheal mucus transport velocities with lung clearance in bronchial asthma and healthy subjects. Ann Occup Hyg (1982) 0.88
Withdrawal of cigarette smoking: a study on tracheobronchial clearance. Arch Environ Health (1973) 0.88
Mycoplasma pneumoniae and tracheobronchial clearance. Am Rev Respir Dis (1974) 0.86
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Sudden death in asthma. Thorax (1979) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Emergency tracheostomy. Practitioner (1975) 2.18
Use of expandable metal stents in the treatment of bronchial obstruction. Thorax (1989) 2.07
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Effects of sputum on pulmonary function. Br Med J (1977) 1.94
A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. Respir Med (2010) 1.92
Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas (1986) 1.87
Evaluation of jet nebulisers for use with gentamicin solution. Thorax (1985) 1.85
Urinary retention and intestinal obstruction associated with ano-rectal Herpes simplex virus infection. Br Med J (1975) 1.83
Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res (1969) 1.77
The normal and abnormal pancreatic scan. Q J Med (1968) 1.74
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Metastatic and histologic presentations in unknown primary cancer. Semin Oncol (1977) 1.61
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest (1993) 1.60
Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother Rep (1975) 1.58
Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA (1979) 1.57
Resistance to two-phase gas-liquid flow in airways. J Appl Physiol (1970) 1.56
Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Chronic pancreatitis in England: a changing picture? Br Med J (1974) 1.46
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax (1986) 1.42
Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest (1989) 1.41
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Pancreatic scanning. Br J Radiol (1976) 1.40
Selective bronchography using the fibreoptic bronchoscope. Br J Dis Chest (1982) 1.36
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis (1978) 1.33
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis (1983) 1.30
The fractional deposition of inhaled 2 and 5 mum particles in the alveolar and tracheobronchial regions of the healthy human lung. Ann Occup Hyg (1976) 1.29
Particle penetration and clearance in the human lung. Results in healthy subjects and subjects with chronic bronchitis. Arch Environ Health (1974) 1.27
Bromhexine and mucociliary clearance in chronic bronchitis. Br J Dis Chest (1974) 1.27
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Aerosol inhalation and depth of deposition in the human lung. The effect of airway obstruction and tidal volume inhaled. Arch Environ Health (1977) 1.19
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat (1986) 1.17
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG). Cancer (1971) 1.17
Radioselenium in duodenal aspirate as an assessment of pancreatic exocrine function. Br Med J (1971) 1.16
Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep (1978) 1.15
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
The effect of expiratory flow rate on regional lung emptying. Clin Sci (1969) 1.15
Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment. Arch Environ Health (1973) 1.15
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13